Keywords: herceptin, shows, unprecendented, stomach, cancer, efficacy, swiss

Herceptin shows "unprecendented" stomach cancer efficacy

Article | 18 May 2009

Print This

Swiss drug major Roche plans to present results from the pivotal ToGA study at the forthcoming American Society of Clinical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in